Recent Advances in Bacopa Monnieri Research: Neuroprotective Effects and Cognitive Decline Mitigation in Neurodegenerative Diseases with a Focus on Alzheimer’s and Parkinson’s Diseases
DOI:
https://doi.org/10.12775/QS.2024.35.56377Keywords
Bacopa Monnieri, Alzheimer's disease, Parkinson's disease, neuroprotection, cognitive decline, cognitive enhancementAbstract
Background: The global rise in neurodegenerative diseases, including Alzheimer’s and Parkinson’s, has increased interest in natural nootropics such as Bacopa Monnieri. Known for its neuroprotective properties, Bacopa Monnieri has a long history in traditional medicine. This review examines its role in cognitive enhancement, focusing on its effects in neurodegenerative diseases.
Methods: Relevant studies published after 2020 were analyzed to assess Bacopa Monnieri’s impact on memory, concentration, and neuroprotection, particularly in Alzheimer’s and Parkinson’s. The review explores mechanisms such as neurotransmitter modulation, reduced neuroinflammation, and enhanced synaptic plasticity.
Results: Bacopa Monnieri exhibits neuroprotective effects beneficial for cognitive health and neurodegenerative diseases. It has antioxidant and anti-inflammatory properties, promotes neurogenesis, and increases Brain-Derived Neurotrophic Factor (BDNF). In Alzheimer’s models, it improved cognitive function, reduced amyloid plaques, and prevented Tau aggregation. In Parkinson’s, it enhanced dopaminergic function and reduced neuroinflammation. Despite promising findings, more robust clinical trials are required to confirm its efficacy.
Conclusion: Bacopa Monnieri demonstrates potential in neuroprotection and cognitive enhancement, particularly in Alzheimer’s and Parkinson’s. It improves synaptic health and reduces oxidative stress and neuroinflammation. However, larger, high-quality trials are needed to fully establish its therapeutic role in neurodegenerative diseases.
References
Agarwal, A., Mishra, B., Gupta, A., Srivastava, M. V. P., Basheer, A., Sharma, J., & Vishnu, V. Y. (2023). Importance of high-quality evidence regarding the use of Bacopa monnieri in dementia. Frontiers in aging neuroscience, 15, 1134775. https://doi.org/10.3389/fnagi.2023.1134775
Banerjee, R., Hazra, S., Ghosh, A. K., & Mondal, A. C. (2014). Chronic administration of bacopa monniera increases BDNF protein and mRNA expressions: a study in chronic unpredictable stress induced animal model of depression. Psychiatry investigation, 11(3), 297–306. https://doi.org/10.4306/pi.2014.11.3.297
Basheer, A., Agarwal, A., Mishra, B., Gupta, A., Padma Srivastava, M. V., Kirubakaran, R., & Vishnu, V. (2022). Use of Bacopa monnieri in the Treatment of Dementia Due to Alzheimer Disease: Systematic Review of Randomized Controlled Trials. Interactive journal of medical research, 11(2), e38542. https://doi.org/10.2196/38542
Bonomi, C. G., Motta, C., Di Donna, M. G., Poli, M., Nuccetelli, M., Bernardini, S., Mercuri, N. B., Koch, G., & Martorana, A. (2024). Age of onset moderates the effects of Vascular Risk Factors on Neurodegeneration, Blood-Brain-Barrier permeability, and cognitive decline in Alzheimer's Disease. Alzheimer's research & therapy, 16(1), 248. https://doi.org/10.1186/s13195-024-01617-2
Can, B., & Sanlier, N. (2024). Alzheimer, Parkinson, dementia, and phytochemicals: insight review. Critical Reviews in Food Science and Nutrition, 1–23. https://doi.org/10.1080/10408398.2023.2299340
Dubey, T., Kushwaha, P., Thulasiram, H. V., Chandrashekar, M., & Chinnathambi, S. (2023). Bacopa monnieri reduces Tau aggregation and Tau-mediated toxicity in cells. International journal of biological macromolecules, 234, 123171. https://doi.org/10.1016/j.ijbiomac.2023.123171
Fatima, U., Roy, S., Ahmad, S., Ali, S., Elkady, W. M., Khan, I., Alsaffar, R. M., Adnan, M., Islam, A., & Hassan, M. I. (2022). Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation. Frontiers in nutrition, 9, 972379. https://doi.org/10.3389/fnut.2022.972379
Ghosh, S., Kumar, V., Mukherjee, H., Saini, S., Gupta, S., Chauhan, S., Kushwaha, K., Lahiri, D., Sircar, D., & Roy, P. (2024). Assessment of the mechanistic role of an Indian traditionally used ayurvedic herb Bacopa monnieri (L.)Wettst. for ameliorating oxidative stress in neuronal cells. Journal of ethnopharmacology, 328, 117899. https://doi.org/10.1016/j.jep.2024.117899
Goyal, A., Gopika, S., Kumar, A., & Garabadu, D. (2022). A Comprehensive Review on Preclinical Evidence-based Neuroprotective Potential of Bacopa monnieri against Parkinson's Disease. Current drug targets, 23(9), 889–901. https://doi.org/10.2174/1389450123666220316091734
Gregory, J., Vengalasetti, Y. V., Bredesen, D. E., & Rao, R. V. (2021). Neuroprotective Herbs for the Management of Alzheimer's Disease. Biomolecules, 11(4), 543. https://doi.org/10.3390/biom11040543
Gupta, V., & Prasad, S. (2024). Differential Alterations in the Expression of AMPA Receptor and Its Trafficking Proteins in the Hippocampus Are Associated with Recognition Memory Impairment in the Rotenone-Parkinson's Disease Mouse Model: Neuroprotective Role of Bacopa monnieri Extract CDRI 08. Molecular neurobiology, 10.1007/s12035-024-04392-1. Advance online publication. https://doi.org/10.1007/s12035-024-04392-1
Jerom, J. P., Madhukumar, S., Nair, R. H., & Narayanan, S. P. (2023). Anti-amyloid potential of some phytochemicals against Aβ-peptide and α-synuclein, tau, prion, and Huntingtin protein. Drug discovery today, 28(12), 103802. https://doi.org/10.1016/j.drudis.2023.103802
Mallick, D., Acharjee, A., Acharjee, P., & Trigun, S. K. (2024). Restoration of hippocampal adult neurogenesis by CDRI-08 (Bacopa monnieri extract) relates with the recovery of BDNF-TrkB levels in male rats with moderate grade hepatic encephalopathy. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 84(6), 510–519. https://doi.org/10.1002/jdn.10350
Marcos-Rabal, P., González-Fuentes, J., Castro-Vázquez, L., Lozano, M. V., Rodríguez-Robledo, V., Santander-Ortega, M. J., Selva-Clemente, J., Villaseca-González, N., & Del Mar Arroyo-Jiménez, M. (2021). Neurodegenerative Diseases: A Multidisciplinary Approach. Current pharmaceutical design, 27(30), 3305–3336. https://doi.org/10.2174/1381612827666210608152745
Nopparat, J., Sujipuli, K., Ratanasut, K., Weerawatanakorn, M., Prasarnpun, S., Thongbai, B., Laothaworn, W., & Inthima, P. (2024). Exploring the excellence of commercial Brahmi products from Thai online markets: Unraveling phytochemical contents, antioxidant properties and DNA damage protection. Heliyon, 10(2), e24509. https://doi.org/10.1016/j.heliyon.2024.e24509
Palollathil, A., Najar, M. A., Amrutha, S., Pervaje, R., Modi, P. K., & Prasad, T. S. K. (2024). Bacopa monnieri confers neuroprotection by influencing signaling pathways associated with interleukin 4, 13 and extracellular matrix organization in Alzheimer's disease: A proteomics-based perspective. Neurochemistry international, 180, 105864. Advance online publication. https://doi.org/10.1016/j.neuint.2024.105864
Santos, A. F. D., Souza, M. M. Q., Amaral, E. C., Albuquerque, E. R., Bortoloti, D. S., Gasparotto Junior, A., Lourenço, E. L. B., Lovato, E. C. W., & Lívero, F. A. D. R. (2023). Bacopa monnieri in Patients with Parkinson's Disease: A Pilot Study. Journal of medicinal food, 26(2), 114–119. https://doi.org/10.1089/jmf.2022.0106
Shoukat, S., Zia, M. A., Uzair, M., Attia, K. A., Abushady, A. M., Fiaz, S., Ali, S., Yang, S. H., & Ali, G. M. (2023). Bacopa monnieri: A promising herbal approach for neurodegenerative disease treatment supported by in silico and in vitro research. Heliyon, 9(11), e21161. https://doi.org/10.1016/j.heliyon.2023.e21161
Singh, B., Pandey, S., Rumman, M., & Mahdi, A. A. (2020). Neuroprotective effects of Bacopa monnieri in Parkinson's disease model. Metabolic brain disease, 35(3), 517–525. https://doi.org/10.1007/s11011-019-00526-w
Sushma, Sahu, M. R., Murugan, N. A., & Mondal, A. C. (2024). Amelioration of Amyloid-β Induced Alzheimer's Disease by Bacopa monnieri through Modulation of Mitochondrial Dysfunction and GSK-3β/Wnt/β-Catenin Signaling. Molecular nutrition & food research, 68(13), e2300245. https://doi.org/10.1002/mnfr.202300245
Valotto Neto, L. J., Reverete de Araujo, M., Moretti Junior, R. C., Mendes Machado, N., Joshi, R. K., Dos Santos Buglio, D., Barbalho Lamas, C., Direito, R., Fornari Laurindo, L., Tanaka, M., & Barbalho, S. M. (2024). Investigating the Neuroprotective and Cognitive-Enhancing Effects of Bacopa monnieri: A Systematic Review Focused on Inflammation, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis. Antioxidants (Basel, Switzerland), 13(4), 393. https://doi.org/10.3390/antiox13040393
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Mateusz Bychowski, Julia Kwaśna, Mateusz Górski, Adrianna Załęska, Izabela Kaźmierczyk, Kacper Lenart, Michał Homza, Natalia Zakrzewska, Szymon Bednarek, Joanna Kulicka
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 95
Number of citations: 0
